News on immunohistochemistry and other tissue-based testing methods.
Abbott highlighted its next-generation Alinity platforms, and Caris discussed its plans to provide precision oncology services.
The firm said that the new financing will help it accelerate commercial initiatives in the US, Europe, Brazil, and Canada.
The company has multiple companion diagnostics partnerships in the works, with new tests on the way in 2020, and new plans for next-generation sequencing.
Proscia said that its partnership with Johns Hopkins, which aims to accelerate research breakthroughs and improve patient outcomes, is one among a number of its recent pathology-related engagements.
Inspirata said that the partners will combine their digital pathology products to address challenges with traditional pathology testing for H. Pylori.
